Misplaced Pages

#496503

61-600: Hollingshead was the Executive Secretary for the Institute of British-American Cultural Exchange in 1961. Dr. John Beresford, a research scientist, received a package of one gram of LSD from Sandoz Laboratories in Switzerland at a time when it was still legal to experiment with it. Beresford, in turn, gave part of the gram to Hollingshead. One of Hollingshead's experiments studied the effects on web-weaving by spiders under

122-552: A dyewood mill and a dye extraction plant. Two years later, they began the production of synthetic fuchsine. In 1901, they formed the public limited company Geigy, and the name of the company was changed to J. R. Geigy Ltd in 1914. CIBA and Geigy merged in 1970 to form Ciba‑Geigy Ltd. / ˌ s iː b ə ˈ ɡ aɪ ɡ i / . In the mid-1990s, state and federal health and environmental agencies identified an increased incidence of childhood cancers in Toms River, New Jersey , from

183-511: A 15 percent stake in Gamida Cell for $ 35 million, with the option to purchase the whole company for approximately $ 165 million. In October 2014, Novartis announced its intention to sell its influenza vaccine business (inclusive of its development pipeline), subject to regulatory approval, to CSL for $ 275 million. In March 2015, the company announced BioPharma had completed its acquisition of two Phase III cancer-drug candidates;

244-432: A 47 percent premium. In March 2018, GlaxoSmithKline announced that it has reached an agreement with Novartis to acquire Novartis' 36.5 percent stake in their Consumer Healthcare Joint Venture for $ 13 billion (£9.2 billion). In April of the same year, the business utilised some of the proceeds from the aforementioned GlaxoSmithKline deal to acquire Avexis for $ 218 per share or $ 8.7 billion in total, gaining

305-422: A better subjective understanding of the schizophrenic experience, and many did exactly that and so did other scientific researchers. The Sandoz product received mass publicity as early as 1954, in a Time magazine feature. Research on LSD peaked in the 1950s and early 1960s. The CIA purchased quantities of LSD from Sandoz for use in its illegal human experimentation program known as MKUltra . Sandoz withdrew

366-522: A clinical-stage SK channel positive allosteric modulator. In September 2021, the company announced it would acquire gene-therapy business, Arctos Medical, broadening its optogenetics range. In December, Novartis announced it would purchase Gyroscope Therapeutics from health care investment company, Syncona Ltd, for up to $ 1.5 billion. In February 2022, New York City-based biotechnology company Cambrian Biopharma announced it had licensed rights to mTOR inhibitor programs from Novartis. As part of

427-477: A developer of technology for delivering RNA-based therapies, upfront for $ 500 million and an additional $ 500 million subject to reaching certain targets. Also in June, Novartis announced it would it would sell Xiidra to Bausch & Lomb for $ 1.75 billion and receive additional $ 750 million linked to future sales for Xiidra as well as two pipeline assets. In September 2023, Novartis announced that

488-564: A fire broke out in a production plant storage room, which led to the Sandoz chemical spill and a large amount of pesticide being released into the upper Rhine river. This exposure killed many fish and other aquatic life. In 1995, Sandoz spun off its specialty chemicals business to form Clariant . In 1997, Clariant merged with the specialty chemicals business that was spun off from Hoechst AG in Germany. In 1996, Ciba-Geigy merged with Sandoz, with

549-529: A new company, Syngenta . In 2003, Novartis organized all its generics businesses into one division, and merged some of its subsidiaries into one company, reusing the predecessor brand name of Sandoz. In 2005, Novartis expanded its subsidiary Sandoz significantly through the US$ 8.29 billion acquisition of Hexal, one of Germany's leading generic drug companies, and Eon Labs, a fast-growing United States generic pharmaceutical company. In 2006, Novartis acquired

610-472: A newly created subsidiary. Endocyte will bolster Novartis' offering in its radiopharmaceuticals business, with Endocyte's first in class candidate Lu-PSMA-617 being targeted against metastatic castration-resistant prostate cancer. In late December the company announced it would acquire France-based contract manufacturer, CellforCure from LFB , boosting its capacity to produce cell and gene therapies. On 9 April 2019, Novartis announced that it had completed

671-670: A short stature. Letrozole has also been used to treat endometriosis . Endometrial stromal sarcomas are hormonally sensitive tumors as it is represented that letrozole reduces serum estrogen levels. Letrozole is well-tolerated and is a good option for long-term management of this disease. Also in a study on Uterine myoma the volume was successfully reduced by use of an aromatase inhibitor. Rapid onset of action and avoidance of initial gonadotropin flare with an aromatase inhibitor. Letrozole has been documented to be safe and effective for improving height and pubertal outcomes in children living with constitutional delay in growth and puberty, and

SECTION 10

#1733086219497

732-637: A strong foundation for our (Novartis') individualized treatment programs". In 2012, the Company cut approximately 2,000 positions in the United States, primarily in sales, in response to anticipated revenue downturns from the hypertension drug Diovan , which was losing patent protection, and the realization that the anticipated successor to Diovan, Rasilez , was failing in clinical trials. The 2012 personnel reductions follow ~2000 cut positions in Switzerland and

793-478: A treatment for gynecomastia , although it is probably most effective at this if caught in an early stage (such as in users of anabolic steroids ). Some studies have shown that letrozole can be used to promote spermatogenesis in male patients with nonobstructive azoospermia . Letrozole has also been shown to delay the fusing of the growth plates in mice. When used in combination with growth hormone, letrozole has been shown effective in one adolescent boy with

854-751: Is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Biotechnology Innovation Organization (BIO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Novartis is the third most valuable pharmaceutical company in Europe, after Novo Nordisk and Roche . Novartis

915-442: Is already working on in 'real-life' situations". The deal will pursue solutions for "organizing and using" data generated from Novartis' laboratory experiments, clinical trials, and manufacturing plants. It will also look at improving manufacturing of Chimeric antigen receptor T cell (CAR T cells). Finally, the deal "will also apply AI to generative chemistry to enhance drug design". In November 2019, Sandoz announced it would acquire

976-597: Is also eligible to receive up to $ 300 million dependent upon future marketing approval milestones outside of America and up to $ 400 million relating to sales milestones. In September 2014, Ophthotech received its first $ 50 million phase III trial milestone payment from Novartis. In April 2014, Novartis announced that it would acquire GlaxoSmithKline 's cancer drug business for $ 16 billion as well as selling its vaccines business to GlaxoSmithKline for $ 7.1 billion. In August 2014 Genetic Engineering & Biotechnology News reported that Novartis had acquired

1037-490: Is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women. Tamoxifen is also used to treat hormonally-responsive breast cancer, but it does so by interfering with the estrogen receptor. However, letrozole is effective only in post-menopausal women, in whom estrogen

1098-806: Is produced predominantly in peripheral tissues (i.e. in adipose tissue, like that of the breast) and a number of sites in the brain. In pre-menopausal women, the main source of estrogen is from the ovaries not the peripheral tissues, and letrozole is ineffective. In the BIG 1–98 Study, of post-menopausal women with hormonally-responsive breast cancer, letrozole reduced the recurrence of cancer, but did not change survival rate, compared to tamoxifen. Letrozole has been used for ovulation induction by fertility doctors since 2001, because it has fewer side-effects than clomiphene (Clomid) and less chance of multiple gestation. A study of 150 babies following treatment with either letrozole alone or letrozole and gonadotropins presented at

1159-484: Is the founder of Sandoz's pharmaceutical department in 1917. In 1918, Arthur Stoll isolated ergotamine from ergot ; the substance was eventually used to treat migraine and headaches and was introduced under the trade name Gynergen in 1921. Between the World Wars, Gynergen (1921) and Calcium-Sandoz (1929) were brought to market. Sandoz also produced chemicals for textiles, paper, and leather , beginning in 1929. In 1939,

1220-527: Is why in certain patient populations such as post-menopausal women or osteoporotics, bisphosphonates may also be prescribed. Letrozole inhibits the liver enzyme CYP2A6 , and to a lesser extent CYP2C19 , in vitro , but no relevant interactions with drugs like cimetidine and warfarin have been observed. Letrozole is an orally active , nonsteroidal , selective aromatase inhibitor and hence an antiestrogen . It prevents aromatase from producing estrogens by competitive , reversible binding to

1281-518: The American Society of Reproductive Medicine 2005 Conference found no difference in overall abnormalities but did find a significantly higher rate of locomotor and cardiac abnormalities among the group having taken letrozole compared to natural conception. A larger, follow-up study with 911 babies compared those born following treatment with letrozole to those born following treatment with clomiphene. That study also found no significant difference in

SECTION 20

#1733086219497

1342-550: The CD20 monoclonal antibody Ofatumumab from GlaxoSmithKline for up to $ 1 billion. In October the company acquired Admune Therapeutics for an undisclosed sum, as well as licensing PBF-509 , an adenosine A2A receptor antagonist which is in Phase I clinical trials for non-small cell lung cancer, from Palobiofarma . In November 2016, the company announced it would acquire Selexys Pharmaceuticals for $ 665 million. In December,

1403-790: The Gerber Products Company to Nestlé as part of its continuing effort to shed old Sandoz and Ciba-Geigy businesses and focus on healthcare. In 2009, Novartis reached an agreement to acquire an 85 percent stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. as part of a strategic initiative to build a vaccines industry leader in this country and expand the group's limited presence in this fast-growing market segment. This proposed acquisition will require government and regulatory approvals in China. In 2010, Novartis offered to pay US$ 39.3 billion to fully acquire Alcon ,

1464-497: The MEK inhibitor binimetinib (MEK 162) and the BRAF inhibitor encorafenib (LGX818), for $ 85 million. In addition, the company sold its RNAi portfolio to Arrowhead Research for $ 10 million and $ 25 million in stock. In June, the company announced it would acquire Spinifex Pharmaceuticals for more than $ 200 million. In August, the company acquired the remaining rights to

1525-408: The heme of its cytochrome P450 unit. The action is specific, and letrozole does not reduce production of corticosteroids . The antiestrogen action of letrozole has been shown to be useful in pretreatment for termination of pregnancy, in combination with misoprostol . It can be used in place of mifepristone , which is expensive and unavailable in many countries. Letrozole is sometimes used as

1586-531: The 1970–1995 period. Multiple investigations by state and federal environmental and health agencies indicated that the likely source of the increased cancer risk was contamination from Toms River Chemical Plant (then operated by Ciba-Geigy), which had been in operation since 1952, and the Reich Farm/Union Carbide. The area was designated a United States Environmental Protection Agency Superfund site in 1983 after an underground plume of toxic chemicals

1647-802: The Beatles . Sandoz Laboratories Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel , Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2020), terbinafine (Lamisil), deferasirox (Exjade), and others. Novartis

1708-583: The California-based Chiron Corporation . Chiron had been divided into three units: Chiron Vaccines, Chiron Blood Testing, and Chiron BioPharmaceuticals. The biopharmaceutical unit was integrated into Novartis Pharmaceuticals, while the vaccines and blood testing units were made into a new Novartis Vaccines and Diagnostics division. Also in 2006, Sandoz became the first company to have a biosimilar drug approved in Europe with its recombinant human growth hormone drug. In 2007, Novartis sold

1769-607: The German chemical maker BASF . In 1998, the company entered into a biotechnology licensing agreement with the University of California at Berkeley Department of Plant and Microbial Biology . Critics of the agreement expressed concern over prospects that the agreement would diminish academic objectivity, or lead to the commercialization of genetically modified plants. The agreement expired in 2003. In 2000, Novartis and AstraZeneca combined their agrobusiness divisions to create

1830-545: The Japanese business of Aspen Global inc for €300 million (around $ 330 million), boosting the business's presence in Asia. In late November 2019, the business announced it would acquire The Medicines Company for US$ 9.7 billion ($ 85 per share) in order to acquire amongst other assets, the cholesterol lowering therapy; inclisiran . In April 2020, the company announced it would acquire Amblyotech. In September 2020, Novartis

1891-737: The Novartis drugs. In October Novartis announced it would acquire Vedere Bio for $ 280 million boosting the businesses cell and gene therapy offerings. In October 2020, as part of a joint venture to develop therapeutic drugs to combat COVID-19 , Novartis bought 6% of all shares outstanding in Swiss DARPin research company Molecular Partners AG at CHF 23 per share. In December 2020, Novartis announced it would acquire Cadent Therapeutics for up to $ 770 million, gaining full rights to CAD-9303 (a NMDAr positive allosteric modulator ), MIJ-821 (a NMDAr negative allosteric modulator ) and CAD-1883

Michael Hollingshead - Misplaced Pages Continue

1952-556: The Toms River water system has been subject to the most stringent water testing in New Jersey and is considered safe for consumption. Dan Fagin 's Toms River: A Story of Science and Salvation , the 2014 Pulitzer Prize winning book, examined the issue of industrial pollution at the site in detail. Sandoz is the generic drugs division of Novartis. Before the 1996 merger with Ciba-Geigy to form Novartis, Sandoz Pharmaceuticals (Sandoz AG)

2013-539: The United States in 2011, ~1400 cut positions in the United States in 2010, and a reduction of "thousands" and several site closures in previous years. Also in 2012, Novartis became the biggest manufacturer of generic skin care medicine, after agreeing to buy Fougera Pharmaceuticals for $ 1.525 billion in cash. In 2013, the Indian Supreme Court issued a decision rejecting Novartis' patent application in India on

2074-482: The brand name Femara among others, is an aromatase inhibitor medication that is used in the treatment of breast cancer . It was patented in 1986 and approved for medical use in 1996. In 2021, it was the 222nd most commonly prescribed medication in the United States, with more than 1   million prescriptions. It is on the World Health Organization's List of Essential Medicines . Letrozole

2135-478: The company Bindschedler and Busch. In 1884, Bindschedler and Busch was transformed into a joint-stock company named " Gesellschaft für Chemische Industrie Basel " (Company for Chemical Industry Basel). The acronym , CIBA, was adopted as the company's name in 1945. The foundation for Geigy was established in 1857, when Johann Rudolf Geigy-Merian (1830–1917) and Johann Muller-Pack acquired a site in Basel, where they built

2196-453: The company acquired Encore Vision , gaining the company's principle compound, EV06, is a first-in-class topical therapy for presbyopia . In December Novartis acquired Ziarco Group Limited, bolstering its presence in eczema treatments. In late October 2017, Reuters announced that Novartis would acquire Advanced Accelerator Applications for $ 3.9 billion, paying $ 41 per ordinary share and $ 82 per American depositary share representing

2257-606: The company began producing agricultural chemicals. The psychedelic effects of lysergic acid diethylamide (LSD) were discovered at the Sandoz laboratories in 1943 by Arthur Stoll and Albert Hofmann . Sandoz began clinical trials and marketed the substance, from 1947 through the mid-1960s, under the name Delysid as a psychiatric drug, thought useful for treating a wide variety of mental ailments , ranging from alcoholism to sexual deviancy . Sandoz suggested in its marketing literature that psychiatrists take LSD themselves, to gain

2318-531: The company violated the False Claims Act and Anti-Kickback Statute by paying physicians to induce them to prescribe certain of the company's drugs. Novartis allegedly spent hundreds of millions of dollars on fraudulent speaker programs that served as a means to bribe doctors with cash payments and other extravagant rewards. Many of these speaking programs were allegedly nothing more than social gatherings at expensive restaurants, with limited or no discussion about

2379-832: The core material for Masters' and Houston's work The Varieties of Psychedelic Experience . In 1965, he moved to London and opened the World Psychedelic Center. He also worked in experimental film, collaborating on the Scott Bartlett short subject "A Trip to the Moon", in 1968. Hollingshead was an associate of the Castalia Foundation , a contributor to the Psychedelic Review , and interviewed cult writer Robert Anton Wilson for High Times magazine in 1980. According to Psychedelia Britannica , Hollingswood died in

2440-542: The deal, Cambrian was setting up a subsidiary called Tornado Therapeutics. In August 2022, the company announced its plan to spin off Sandoz generic drugs unit to form a publicly traded business as part of a restructuring. With the unit having generated US$ 9.69 billion in 2021, the spin-off would create the biggest generic drugs company in Europe by sales. In June 2023, Novartis announced it would acquire Chinook Therapeutics and its drug pipeline for up to $ 3.5 billion. In July 2023, Novartis acquired DTx Pharma,

2501-537: The drug from the market in 1965. The drug became a cultural novelty of the 1960s after psychologist Timothy Leary at Harvard University began to promote its use for recreational and spiritual experiences among the general public. Sandoz opened its first foreign offices in 1964. In 1967, Sandoz merged with Wander AG (known for Ovomaltine and Isostar ). Sandoz acquired the companies Delmark , Wasabröd (a Swedish manufacturer of crisp bread ), and Gerber Products Company (a baby food company). On 1 November 1986,

Michael Hollingshead - Misplaced Pages Continue

2562-688: The early 1980s. In a 2018 interview, Hollingshead's daughter Vanessa said that her father died in Bolivia from a stomach ulcer in 1984. Apart from Leary, those Hollingshead is reputed to have introduced to LSD include writers William S. Burroughs and Paul Krassner , comparative religions scholar Huston Smith , philosopher Alan Watts , graphic designer Storm Thorgerson , film director Roman Polanski , poet Allen Ginsberg , businessman-financier Saul Steinberg , musicians Donovan , Keith Richards , Pete LaRoca , Charles Mingus , Maynard Ferguson and Paul McCartney , John Lennon , and George Harrison of

2623-515: The final form of Gleevec , Novartis's cancer drug; the case caused great controversy. In 2013, Novartis was sued again by the US government, this time for allegedly bribing doctors for a decade so that their patients are steered towards the company's drugs. In January 2014, Novartis announced plans to cut 500 jobs from its pharmaceuticals division. In February 2014, Novartis announced that it acquired CoStim Pharmaceuticals. In May 2014, Novartis purchased

2684-529: The influence of the drug. Hollingshead claims to have first tried LSD by licking the spoon of a batch of LSD-laced cake icing he had packed in a mayonnaise jar for transport. (This jar was to become the object of psychedelic legend.) Following this first experience, Hollingshead contacted Aldous Huxley , who suggested he get in contact with Timothy Leary to discuss the potential of the drug. In September 1961, Hollingshead met Leary in Cambridge, Massachusetts , and

2745-494: The lead compound AVXS-101 used to treat spinal muscular atrophy . In August 2018, Novartis signed a deal with Laekna-a Shanghai-based pharmaceutical company for its two clinical-stage cancer drugs. Novartis gave Laekna the exclusive international rights for the drugs that are oral pan-Akt kinase inhibitors namely; afuresertib (ASB138) and uprosertib (UPB795). In mid-October, the company announced it would acquire Endocyte Inc for $ 2.1 billion ($ 24 per share) merging it with

2806-451: The pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were spun off as independent companies. notably Ciba Specialty Chemicals . Sandoz's Master Builders Technologies, a producer of chemicals for the construction industry, was sold off to SKW Trostberg A.G., a subsidiary of the German energy company VIAG , while its North American corn herbicide business became part of

2867-466: The rate of overall abnormalities, but found that congenital cardiac anomalies was significantly higher in the clomiphene group compared to the letrozole group. Despite this, India banned the usage of letrozole in 2011, citing potential risks to infants. In 2012, an Indian parliamentary committee said that the drug controller office colluded with letrozole's makers to approve the drug for infertility in India and also stated that letrozole's use for infertility

2928-462: The rights to market Ophthotech 's Fovista (an anti- PDGF aptamer , also being investigated for use in combination with anti- VEGF treatments) outside the U.S. for up to $ 1 billion. Novartis acquired exclusive rights to market the eye drug outside of the states while retaining U.S. marketing rights. The company agreed to pay Ophthotech $ 200 million upfront, and $ 130 million in milestone payments relating to Phase III trials. Ophthotech

2989-407: The side effects of anabolic steroids . Letrozole is contraindicated in women having a pre- menopausal hormonal status, during pregnancy and lactation. The most common side effects are sweating, hot flushes , arthralgia (joint pain), and fatigue . Generally, side effects include signs and symptoms of hypoestrogenism . There is concern that long term use may lead to osteoporosis , which

3050-969: The spin-off had been approved by its shareholders and that it would be completed by the next month, resulting in Novartis shareholders receiving one Sandoz share for every five Novartis shares. Sandoz will be listed on the SIX Swiss Exchange with a market capitalization between $ 18 billion and $ 25bn. On 4 October 2023, Novartis completed the spin-off of Sandoz as a stand-alone company. In November 2023, Legend Biotech and Novartis signed an out-license deal to develop and manufacture Legend's chimeric antigen receptor (CAR-T) therapies, that go after delta-like ligand protein 3 (DLL3) including large cell neuroendocrine carcinoma candidate LB2102 for $ 100 million upfront, and Legend Biotech will be eligible to receive up to $ 1.01 billion in clinical, regulatory, and commercial milestone payments and tiered royalties. Letrozole Letrozole , sold under

3111-460: The spin-off of Alcon as a separate commercial entity. Alcon was listed on the SIX exchange in Switzerland and NYSE exchange in the U.S. Novartis announced during late 2019 a five-year artificial intelligence "alliance" with Microsoft. The companies aim to create applications for "Microsoft's AI capabilities", in turn improving the other's drug development processes. Microsoft seeks to "test AI products it

SECTION 50

#1733086219497

3172-463: The world's largest eye-care company, including a majority stake held by Nestlé. Novartis had bought 25 percent of Alcon in 2008. Novartis created a new division and called it Alcon, under which it placed its CIBA VISION subsidiary and Novartis Ophthalmics, which became the second-largest division of Novartis. The total cost for Alcon amounted to $ 60 billion. In 2011, Novartis acquired the medical laboratory diagnostics company Genoptix to "serve as

3233-448: Was a pharmaceutical company headquartered in Basel , Switzerland (as was Ciba-Geigy), and was best known for developing drugs such as Sandimmune for organ transplantation , the antipsychotic Clozaril , Mellaril Tablets and Serentil Tablets for treating psychiatric disorders , and Cafergot Tablets and Torecan Suppositories for treating migraine headaches . The Chemiefirma Kern und Sandoz ("Kern and Sandoz Chemistry Firm")

3294-495: Was created in March 1996 and began operations on 20 December from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in 1857) and CIBA (founded in Basel in 1859). Ciba began in 1859, when Alexander Clavel (1805–1873) took up the production of fuchsine in his factory for silk -dyeing works in Basel. By 1873, he sold his dye factory to

3355-565: Was formed in 1996 by the merger of Ciba-Geigy and Sandoz . It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes” (new skills). After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals , spun off as independent companies. The Sandoz brand disappeared for three years, but

3416-489: Was founded in 1886 by Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928). The first dyes manufactured by them were alizarinblue and auramine . After Kern's death, the partnership became the corporation Chemische Fabrik vormals Sandoz in 1895. The company began producing the fever-reducing drug antipyrin in the same year. In 1899, the company began producing the sugar substitute saccharin . Further pharmaceutical research began in 1917 under Arthur Stoll (1887–1971), who

3477-446: Was identified. The following year, a discharge pipe was shut down after a sinkhole at the corner of Bay Avenue and Vaughn Avenue revealed that it had been leaking. The plant ceased operation in 1996. A follow-up study from the 1996–2000 period indicated that while there were more cancer cases than expected, rates had significantly fallen and the difference was statistically insignificant compared to normal statewide cancer rates. Since 1996,

3538-571: Was illegal worldwide; however, such off-label uses are legal in many countries such as the US and UK. Tests have shown that the efficacy of first-trimester medical abortions (using misoprostol ) can be improved by including letrozole in the drug regimen. Letrozole is considered a performance enhancing drug by the World Antidoping Agency (WADA), as are other aromatase inhibitors, despite not having any documented evidence for enhancing performance, because it may be used to counteract

3599-524: Was imposed a fine of €385 million by the French competition authority on accusations of abusive practices to preserve sales of Lucentis over a cheaper drug. Also in September, BioNTech has leased a large production facility from Novartis to follow all advance demands for its coronavirus vaccine in Europe and sell it to China. In July 2020, Novartis agreed to pay $ 678 million to settle allegations that

3660-628: Was invited to live in the latter's house and teach a course at Harvard. Shortly thereafter, he introduced Leary to LSD. Hollingshead participated in the Concord Prison Experiment with Leary, Ralph Metzner , and others in 1962. For the next few years he worked with psychedelic therapists, and lived at Millbrook, New York with Leary and Richard Alpert (a.k.a. Ram Dass ). He then set up a New York-based project of his own together with Jean Houston , where guided trips were performed and data gathered which, according to Hollingshead's book, formed

3721-432: Was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca , which also divested its agrochemical business. The new company also acquired a series of acquisitions in order to strengthen its core businesses. Novartis

SECTION 60

#1733086219497
#496503